Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Panitumumab with Cisplatin and Gemcitabine in KRAS Wild-Type Biliary Tract Cancer
NCT01320254Phase 2Completed
- Sponsor
- Hannover Medical School
- Start
- Jun 2011
- Primary completion
- Sep 2016
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of panitumumab in cholangiocarcinoma (CCA), gallbladder carcinoma, sponsored by Hannover Medical School. Started Jun 2011; status: completed.
02
Drugs
panitumumab
03
Conditions
cholangiocarcinoma (CCA)gallbladder carcinoma
Beyond the preview
Go deeper on NCT01320254.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01320254.